Zoetis Inc.

ZTS | NYSE | CIK: 0001555280 | SIC: 2834 Pharmaceutical Preparations | active
Parsippany, New Jersey | Founded: 2012
Zoetis Inc. is a global animal health company focused on the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests, and precision animal health solutions. It serves eight core species across companion animals (dogs, cats, horses) and livestock (cattle, swine, poultry, fish, sheep). Key products include Apoquel, Cytopoint, Librela, Simparica, and Fostera. In 2025, the company reported total revenue of approximately $9.35 billion across U.S. and International segments.
companion-animal-health-(dogs,-cats,-horses)livestock-health-(cattle,-swine,-poultry,-fish,-sheep)animal-health-diagnosticsparasiticidesvaccinesdermatologyanti-infectivespain-and-sedationbiodevices-and-genetic-testingcontract-manufacturing-services

Products

NameTypeDescription
Apoquel (oclacitinib)serviceFirst Janus kinase inhibitor in veterinary medicine for control of pruritus and atopic dermatitis in dogs.
Cytopoint (lokivetmab)serviceFirst canine monoclonal antibody to reduce clinical signs of atopic dermatitis and allergic dermatitis in dogs.
Librela (bedinvetmab)serviceFirst injectable monoclonal antibody therapy for alleviation of osteoarthritis pain in dogs.
Solensia (frunevetmab)serviceFirst injectable monoclonal antibody therapy for alleviation of osteoarthritis pain in cats.
Simparica (sarolaner)serviceMonthly oral chewable tablet to prevent fleas and ticks in dogs, launched February 2016.
Simparica TrioserviceCombines sarolaner, moxidectin, and pyrantel for protection against fleas, ticks, heartworm, and GI nematodes in dogs.
Revolution Plus/Stronghold Plus (selamectin/sarolaner)serviceTreatment for fleas, ticks, ear mites, lice, GI worms, and prevention of heartworm disease in cats.
Lenivia (izenivetmab)serviceFirst long-acting injectable monoclonal antibody therapy with three-month dosing interval for OA pain in dogs.
Core EQ InnovatorserviceFirst and only equine vaccine containing all five core disease antigens in one combination, approved in U.S. in 2018.
Fostera/Suvaxyn PCV MHserviceSwine vaccine protecting against porcine circovirus-associated disease and enzootic pneumonia caused by M. hyopneumoniae.

Partnerships

PartnerTypeDescription
Pfizer Inc.strategicZoetis was formerly a business unit of Pfizer before incorporation as an independent entity in July 2012.

SEC Filings

View all SEC EDGAR filings: EDGAR Company Page

Structured filing index: /api/company/ZTS/filings

Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking.
AI Discovery Document | Registry Metrics | GitHub